These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

496 related articles for article (PubMed ID: 14511229)

  • 1. The MHC class I antigen presentation pathway: strategies for viral immune evasion.
    Hewitt EW
    Immunology; 2003 Oct; 110(2):163-9. PubMed ID: 14511229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Equine herpesvirus type 4 UL56 and UL49.5 proteins downregulate cell surface major histocompatibility complex class I expression independently of each other.
    Said A; Azab W; Damiani A; Osterrieder N
    J Virol; 2012 Aug; 86(15):8059-71. PubMed ID: 22623773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Flow Cytometry-Based Approach to Unravel Viral Interference with the MHC Class I Antigen Processing and Presentation Pathway.
    Praest P; de Buhr H; Wiertz EJHJ
    Methods Mol Biol; 2019; 1988():187-198. PubMed ID: 31147941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular mechanisms of viral immune evasion proteins to inhibit MHC class I antigen processing and presentation.
    Zhou F
    Int Rev Immunol; 2009; 28(5):376-93. PubMed ID: 19811316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Herpesviruses and immunity: the art of evasion.
    Griffin BD; Verweij MC; Wiertz EJ
    Vet Microbiol; 2010 Jun; 143(1):89-100. PubMed ID: 20303681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Viral immune evasion: Lessons in MHC class I antigen presentation.
    van de Weijer ML; Luteijn RD; Wiertz EJ
    Semin Immunol; 2015 Mar; 27(2):125-37. PubMed ID: 25887630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of MHC class I antigen presentation by viral proteins.
    Früh K; Ahn K; Peterson PA
    J Mol Med (Berl); 1997 Jan; 75(1):18-27. PubMed ID: 9020380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New insights into the structure of the MHC class I peptide-loading complex and mechanisms of TAP inhibition by viral immune evasion proteins.
    Praest P; Liaci AM; Förster F; Wiertz EJHJ
    Mol Immunol; 2019 Sep; 113():103-114. PubMed ID: 29606337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of viral interference with MHC class I antigen processing and presentation.
    Yewdell JW; Bennink JR
    Annu Rev Cell Dev Biol; 1999; 15():579-606. PubMed ID: 10611973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Viral immune evasion molecules attack the ER peptide-loading complex and exploit ER-associated degradation pathways.
    Lybarger L; Wang X; Harris M; Hansen TH
    Curr Opin Immunol; 2005 Feb; 17(1):71-8. PubMed ID: 15653314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Herpesviruses placating the unwilling host: manipulation of the MHC class II antigen presentation pathway.
    Zuo J; Rowe M
    Viruses; 2012 Aug; 4(8):1335-53. PubMed ID: 23012630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of viral immune escape strategies targeting the MHC class I assembly pathway.
    Früh K; Gruhler A; Krishna RM; Schoenhals GJ
    Immunol Rev; 1999 Apr; 168():157-66. PubMed ID: 10399072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Receptor modulation in viral replication: HIV, HSV, HHV-8 and HPV: same goal, different techniques to interfere with MHC-I antigen presentation.
    Piguet V
    Curr Top Microbiol Immunol; 2005; 285():199-217. PubMed ID: 15609505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MHC class I antigen presentation: learning from viral evasion strategies.
    Hansen TH; Bouvier M
    Nat Rev Immunol; 2009 Jul; 9(7):503-13. PubMed ID: 19498380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Viral evasion of the MHC class I antigen-processing machinery.
    Loch S; Tampé R
    Pflugers Arch; 2005 Dec; 451(3):409-17. PubMed ID: 16086162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of viral interference with MHC class I-restricted antigen processing and presentation using a flow cytometry-based approach.
    Horst D; Ressing ME; Mulder A; Wiertz EJHJ
    Methods Mol Biol; 2013; 960():127-136. PubMed ID: 23329483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploiting human herpesvirus immune evasion for therapeutic gain: potential and pitfalls.
    Horst D; Ressing ME; Wiertz EJ
    Immunol Cell Biol; 2011 Mar; 89(3):359-66. PubMed ID: 21301483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Viral interference with MHC class I antigen presentation pathway: the battle continues.
    Ambagala AP; Solheim JC; Srikumaran S
    Vet Immunol Immunopathol; 2005 Aug; 107(1-2):1-15. PubMed ID: 15978672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Viral modulation of antigen presentation: manipulation of cellular targets in the ER and beyond.
    Lilley BN; Ploegh HL
    Immunol Rev; 2005 Oct; 207():126-44. PubMed ID: 16181332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Host immune system strikes back: autophagy-mediated antigen presentation bypasses viral blockade of the classic MHC class I processing pathway.
    Tey SK; Khanna R
    Autophagy; 2012 Dec; 8(12):1839-41. PubMed ID: 22932396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.